Achilles Therapeutics (ACHL)

Achilles Therapeutics (ACHL) Financial Statements


Achilles Therapeutics Financial Overview

Achilles Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Achilles Therapeutics is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -16.03M$ -20.55M$ -18.97M
EBITDA--$ -16.03M$ -19.63M$ -17.92M
Net Income Common Stockholders--$ -12.48M$ -17.29M$ -17.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 131.54M$ 173.34M$ 179.89M$ 201.59M$ 236.93M
Total Assets$ 161.46M$ 220.36M$ 227.35M$ 257.72M$ 292.19M
Total Debt$ 4.62M$ 8.58M$ 8.99M$ 10.12M$ 11.88M
Net Debt$ -126.92M$ -164.76M$ -170.90M$ -191.47M$ -225.05M
Total Liabilities$ 19.09M$ 23.31M$ 24.73M$ 26.13M$ 25.73M
Stockholders Equity$ 142.37M$ 197.04M$ 202.62M$ 231.59M$ 266.45M
Cash Flow-
Free Cash Flow---$ -18.14M$ -22.50M
Operating Cash Flow---$ -16.41M$ -20.64M
Investing Cash Flow---$ -1.74M$ -1.86M
Financing Cash Flow---$ 0.00$ 0.00
Currency in USD

Achilles Therapeutics Earnings and Revenue History

Achilles Therapeutics Debt to Assets

Achilles Therapeutics Cash Flow

Achilles Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis